Orchestra BioMed Presents Virtue SAB at TCT Symposium

PUBT · 10/29 12:31
Orchestra BioMed Presents Virtue SAB at TCT Symposium
  • Orchestra BioMed's Virtue SAB will be featured at TCT 2026, running Oct. 31-Nov. 3 at the San Diego Convention Center.
  • Allen Jeremias will present Nov. 1, 2026, from 9:03-9:10 a.m. PT, covering the balloon's drug-delivery mechanism, clinical evidence and pivotal trial design.
  • The enrolling Virtue Trial targets approximately 740 patients, comparing Virtue SAB with the AGENT paclitaxel-coated balloon for coronary in-stent restenosis.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610290830PRIMZONEFULLFEED9855844) on October 29, 2026, and is solely responsible for the information contained therein.